Search

Your search keyword '"Stenke A"' showing total 2,079 results

Search Constraints

Start Over You searched for: Author "Stenke A" Remove constraint Author: "Stenke A"
2,079 results on '"Stenke A"'

Search Results

203. Neue Liste FuE-intensiver Güter und Wirtschaftszweige sowie wissensintensiver Wirtschaftszweige 2021

204. Springtime arctic ozone depletion forces northern hemisphere climate anomalies

206. Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors : Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

207. Detection of reactive nitrogen containing particles in the tropopause region – evidence for a tropical nitric acid trihydrate (NAT) belt

208. AirClim: an efficient tool for climate evaluation of aircraft technology

209. Radiative forcing from particle emissions by future supersonic aircraft

210. Do supersonic aircraft avoid contrails?

212. Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP:Five-year follow-up of the NordCML007 study

213. The acute radiation syndrome-need for updated medical guidelines

214. Climate impact of supersonic air traffic: an approach to optimize a potential future supersonic fleet ─ results from the EU-project SCENIC

215. Weakening of springtime Arctic ozone depletion with climate change.

216. Et Anima Est Sanguis et Sanguis Est Anima: 'First let's make poems, with blood': VestAndPage blood writing.

217. Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

220. NADPH oxidase 4 is protective and not fibrogenic in intestinal inflammation

222. Stratospheric Aerosol--Observations, Processes, and Impact on Climate

223. Long-term changes and variability in a transient simulation with a chemistry-climate model employing realistic forcing

224. Simulation of stratospheric water vapor trends: impact on stratospheric ozone chemistry

229. Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

230. Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells

231. Parts and Wholes in Long Non-narrative Poems of the Eighteenth Century

232. Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI

234. Treatment-Free Remission (TFR) after Two Different Durations of Nilotinib Consolidation in Patients with Chronic Myeloid Leukemia (CML) Previously Treated with Imatinib: Enestpath Study Results

236. Increased Risk of Chronic Myeloid Leukemia Following Gastric Conditions Indicating Helicobacter pylori Infection: A Case–Control Study

237. Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

240. Inter-model comparison of global hydroxyl radical (OH) distributions and their impact on atmospheric methane over the 2000–2016 period

241. The effect of atmospheric nudging on the stratospheric residual circulation in chemistry–climate models

242. Improved tropospheric and stratospheric sulfur cycle in the aerosol–chemistry–climate model SOCOL-AERv2

243. Clear-sky ultraviolet radiation modelling using output from the Chemistry Climate Model Initiative

244. Reactive nitrogen (NOy) and ozone responses to energetic electron precipitation during Southern Hemisphere winter

245. Evaluating the Relationship between Interannual Variations in the Antarctic Ozone Hole and Southern Hemisphere Surface Climate in Chemistry–Climate Models

246. Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

247. Exploring accumulation-mode H2SO4 versus SO2 stratospheric sulfate geoengineering in a sectional aerosol–chemistry–climate model

248. Tropospheric Ozone at Northern Mid-Latitudes: Modeled and Measured Long-Term Changes

250. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

Catalog

Books, media, physical & digital resources